I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Nätynki, Antti
14
results:
Format
Online (14)
Mediatypes
Articles (Online) (4)
OpenAccess-fulltext (10)
Sorted by: Relevance
Sorted by: Year
?
1
Proteomic changes related to actin cytoskeleton function in..:
Nätynki, Antti
;
Kokkonen, Nina
;
Tuusa, Jussi
...
Journal of Dermatological Science. 113 (2024) 3 - p. 121-129 , 2024
Link:
https://doi.org/10.1016/..
?
2
Use of gliptins reduces levels of SDF-1/CXCL12 in bullous p..:
Nätynki, Antti
;
Leisti, Päivi
;
Tuusa, Jussi
...
Frontiers in Immunology. 13 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
3
Autoantibodies Against the Immunodominant Bullous Pemphigoi..:
Nätynki, Antti
;
Tuusa, Jussi
;
Hervonen, Kaisa
...
Frontiers in Immunology. 11 (2020) - p. , 2020
Link:
https://doi.org/10.3389/..
?
4
CD200 Positive Human Mesenchymal Stem Cells Suppress TNF-Al..:
Pietilä, Mika
;
Lehtonen, Siri
;
Tuovinen, Elina
...
PLoS ONE. 7 (2012) 2 - p. e31671 , 2012
Link:
https://doi.org/10.1371/..
?
5
Use of gliptins reduces levels of SDF-1/CXCL12 in bullous p..:
Nätynki, A. (Antti)
;
Leisti, P. (Päivi)
;
Tuusa, J. (Jussi)
... , 2022
Link:
http://urn.fi/urn:nbn:fi..
?
6
Use of gliptins reduces levels of SDF-1/CXCL12 in bullous p..:
Nätynki, Antti
;
Leisti, Päivi
;
Tuusa, Jussi
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357937/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
7
Autoantibodies against the immunodominant bullous pemphigoi..:
Nätynki, A. (Antti)
;
Tuusa, J. (Jussi)
;
Hervonen, K. (Kaisa)
... , 2020
Link:
http://urn.fi/urn:nbn:fi..
?
8
Autoantibodies Against the Immunodominant Bullous Pemphigoi..:
Nätynki, Antti
;
Tuusa, Jussi
;
Hervonen, Kaisa
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544946/. , 2020
Link:
http://www.ncbi.nlm.nih...
?
9
Autoantibodies Against the Immunodominant Bullous Pemphigoi..:
Nätynki, Antti
;
Tuusa, Jussi
;
Hervonen, Kaisa
...
575805. , 2020
Link:
https://trepo.tuni.fi/ha..
?
10
Use of gliptins reduces levels of SDF-1/CXCL12 in bullous p..:
Antti Nätynki
;
Päivi Leisti
;
Jussi Tuusa
...
https://www.frontiersin.org/articles/10.3389/fimmu.2022.942131/full. , 2022
Link:
https://doi.org/10.3389/..
?
11
DataSheet_1_Use of gliptins reduces levels of SDF-1/CXCL12 ..:
Antti Nätynki
;
Päivi Leisti
;
Jussi Tuusa
...
doi:10.3389/fimmu.2022.942131.s001. , 2022
Link:
https://doi.org/10.3389/..
?
12
Table_1_Autoantibodies Against the Immunodominant Bullous P..:
Antti Nätynki
;
Jussi Tuusa
;
Kaisa Hervonen
...
doi:10.3389/fimmu.2020.575805.s001. , 2020
Link:
https://doi.org/10.3389/..
?
13
Autoantibodies Against the Immunodominant Bullous Pemphigoi..:
Antti Nätynki
;
Jussi Tuusa
;
Kaisa Hervonen
...
https://www.frontiersin.org/article/10.3389/fimmu.2020.575805/full. , 2020
Link:
https://doi.org/10.3389/..
?
14
CD200 positive human mesenchymal stem cells suppress TNF-al..:
Mika Pietilä
;
Siri Lehtonen
;
Elina Tuovinen
...
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22363701/pdf/?tool=EBI. , 2012
Link:
https://doi.org/10.1371/..
1-14